HUTCHMED (China) Limited Sponsored ADR (HCM)
(Delayed Data from NSDQ)
$15.00 USD
-1.31 (-8.03%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $14.98 -0.02 (-0.13%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth A Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
HCM 15.00 -1.31(-8.03%)
Will HCM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for HCM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HCM
How Much Upside is Left in HUTCHMED (HCM)? Wall Street Analysts Think 73.52%
Wall Street Analysts See a 68.3% Upside in HUTCHMED (HCM): Can the Stock Really Move This High?
HCM: What are Zacks experts saying now?
Zacks Private Portfolio Services
HUTCHMED (HCM) Upgraded to Buy: Here's Why
Wall Street Analysts Believe HUTCHMED (HCM) Could Rally 72.83%: Here's is How to Trade
Other News for HCM
HUTCHMED (China) Limited (HCM) Q2 2025 Earnings Call Transcript
HUTCHMED (China) Ltd (HCM) (H1 2025) Earnings Call Highlights: Navigating Challenges with ...
Half Year 2025 HUTCHMED (China) Ltd Earnings Call Transcript
HUTCHMED reports mixed 1H results; updates FY25 outlook
Hutchmed reports 1H EPS $2.61 vs. 15c last year